Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Experimental & Molecular Medicine ; : 509-518, 2006.
Artículo en Inglés | WPRIM | ID: wpr-69447

RESUMEN

Angiotensin II (Ang II), which is an important mediator of both vascular responsiveness and growth, has been shown to induce vascular smooth muscle cell (VSMC) hypertrophy via the activation of a complex series of intracellular signaling events. Heat shock protein 70 (Hsp70) has recently been shown to protect against Ang II-induced hypertension. In this study, we tested the hypothesis that Hsp70 can protect VSMC from Ang II-induced hypertrophy. We treated VSMCs with Ang II to induce hypertrophy and to activate MAPK signaling pathway. We observed that the augmentation of Hsp70 expression inhibited Ang II-stimulated VSMC hypertrophy. This inhibitory effect of Hsp70 appears to be partly due to extracellular signal-regulated kinase (ERK1/2) inactivation, which in turn, may possibly result from the accumulation of MAP kinase phosphatase-1 (MKP-1).


Asunto(s)
Ratas , Masculino , Animales , Ratas Sprague-Dawley , ARN Interferente Pequeño/farmacología , Proteínas Tirosina Fosfatasas/metabolismo , Fosfoproteínas Fosfatasas/metabolismo , Músculo Liso Vascular/citología , Proteína Quinasa 3 Activada por Mitógenos/antagonistas & inhibidores , Proteína Quinasa 1 Activada por Mitógenos/antagonistas & inhibidores , MAP Quinasa Quinasa 2/metabolismo , MAP Quinasa Quinasa 1/metabolismo , Proteínas Inmediatas-Precoces/metabolismo , Hipertrofia , Proteínas HSP70 de Choque Térmico/antagonistas & inhibidores , Flavonoides/farmacología , Estabilidad de Enzimas/efectos de los fármacos , Células Cultivadas , Proteínas de Ciclo Celular/metabolismo , Aorta/efectos de los fármacos , Angiotensina II/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA